scholarly journals Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab

Diabetologia ◽  
2018 ◽  
Vol 61 (4) ◽  
pp. 743-750 ◽  
Author(s):  
Alison D. McNeilly ◽  
Rory J. McCrimmon
2015 ◽  
Vol 33 (1) ◽  
pp. 77-83 ◽  
Author(s):  
A.-S. Sejling ◽  
B. Schouwenberg ◽  
L. H. Faerch ◽  
B. Thorsteinsson ◽  
B. E. de Galan ◽  
...  

2005 ◽  
Vol 50 (10) ◽  
pp. 530-533 ◽  
Author(s):  
Andreas Holstein ◽  
Armin Plaschke ◽  
Michael Stumvoll ◽  
Peter Kovacs

2011 ◽  
Vol 61 (4) ◽  
pp. 241-246 ◽  
Author(s):  
O. O. Ogundipe ◽  
J. Geddes ◽  
A. M. Leckie ◽  
B. M. Frier

PLoS ONE ◽  
2013 ◽  
Vol 8 (8) ◽  
pp. e72876 ◽  
Author(s):  
Eleonora Seelig ◽  
Stefan Bilz ◽  
Ulrich Keller ◽  
Fabian Meienberg ◽  
Mirjam Christ-Crain

2014 ◽  
Vol 2 (5) ◽  
pp. 1-188 ◽  
Author(s):  
Simon Heller ◽  
Julia Lawton ◽  
Stephanie Amiel ◽  
Debbie Cooke ◽  
Peter Mansell ◽  
...  

BackgroundMany adults with type 1 diabetes cannot self-manage their diabetes effectively and die prematurely with diabetic complications as a result of poor glucose control. Following the positive results obtained from a randomised controlled trial (RCT) by the Dose Adjustment For Normal Eating (DAFNE) group, published in 2002, structured training is recommended for all adults with type 1 diabetes in the UK.AimWith evidence that blood glucose control is not always improved or sustained, we sought to determine factors explaining why some patients benefit from training more than other patients, identifying barriers to successful self-management, while developing other models to make skills training more accessible and effective.FindingsWe confirmed that glycaemic outcomes are not always improved or sustained when the DAFNE programme is delivered routinely, although improvements in psychosocial outcomes are maintained. DAFNE courses and follow-up support is needed to help participants instil and habituate key self-management practices such as regular diary/record keeping. DAFNE graduates need structured professional support following training. This is currently either unavailable or provided ad hoc without a supporting evidence base. Demographic and psychosocial characteristics had minimal explanatory power in predicting glycaemic control but good explanatory power in predicting diabetes-specific quality of life over the following year. We developed a DAFNE course delivered for 1 day per week over 5 weeks. There were no major differences in outcomes between this and a standard 1-week DAFNE course; in both arms of a RCT, glycaemic control improved by less than in the original DAFNE trial. We piloted a course delivering both the DAFNE programme and pump training. The pilot demonstrated the feasibility of a full multicentre RCT and resulted in us obtaining subsequent Health Technology Assessment programme funding. In collaboration with the National Institute for Health Research (NIHR) Diabetes Research Programme at King’s College Hospital (RG-PG-0606-1142), London, an intervention for patients with hypoglycaemic problems, DAFNE HART (Dose Adjustment for Normal Eating Hypoglycaemia Awareness Restoration Training), improved impaired hypoglycaemia awareness and is worthy of a formal trial. The health economic work developed a new type 1 diabetes model and confirmed that the DAFNE programme is cost-effective compared with no structured education; indeed, it is cost-saving in the majority of our analyses despite limited glycated haemoglobin benefit. Users made important contributions but this could have been maximised by involving them with grant writing, delaying training until the group was established and funding users’ time off work to maximise attendance. Collecting routine clinical data to conduct continuing evaluated roll-out is possible but to do this effectively requires additional administrator support and/or routine electronic data capture.ConclusionsWe propose that, in future work, we should modify the current DAFNE curricula to incorporate emerging understanding of behaviour change principles to instil and habituate key self-management behaviours that include key DAFNE competencies. An assessment of numeracy, critical for insulin dose adjustment, may help to determine whether or not additional input/support is required both before and after training. Models of structured support involving professionals should be developed and evaluated, incorporating technological interventions to help overcome the barriers identified above and enable participants to build effective self-management behaviours into their everyday lives.Trial registrationClinicalTrials.gov NCT01069393.FundingThe NIHR Programme Grants for Applied Research programme.


BMJ Open ◽  
2019 ◽  
Vol 9 (6) ◽  
pp. e030356 ◽  
Author(s):  
Stephanie A Amiel ◽  
Pratik Choudhary ◽  
Peter Jacob ◽  
Emma Lauretta Smith ◽  
Nicole De Zoysa ◽  
...  

IntroductionSevere hypoglycaemia (SH), when blood glucose falls too low to support brain function, is the most feared acute complication of insulin therapy for type 1 diabetes mellitus (T1DM). 10% of people with T1DM contribute nearly 70% of all episodes, with impaired awareness of hypoglycaemia (IAH) a major risk factor. People with IAH may be refractory to conventional approaches to reduce SH, with evidence for cognitive barriers to hypoglycaemia avoidance. This paper describes the protocol for the Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc) study, a trial to assess the impact on hypoglycaemia experience of a novel intervention that addresses cognitive barriers to hypoglycaemia avoidance, compared with an existing control intervention, recommended by the National Institute of Health and Care Excellence.Methods and analysisA randomised parallel two-arm trial of two group therapies: HARPdoc versus Blood Glucose Awareness Training, among 96 adults with T1DM and problematic hypoglycaemia, despite attendance at education with or without technology use, in four centres providing specialist T1DM services. The primary outcome will be the SH rate at 12 and/or 24 months after randomisation to either course. Secondary outcomes include rates of SH requiring parenteral therapy, involving unconsciousness or needing emergency services; hypoglycaemia awareness status, overall diabetes control and quality of life measures. An implementation study to evaluate how the interventions are delivered and how implementation impacts on clinical effectiveness is planned as a parallel study, with its own protocol.Ethics and disseminationThe protocol was approved by the London Dulwich Research Ethics Committee, the Health Research Authority, National Health Service R&D and the Institutional Review Board of the Joslin Diabetes Center in the USA. Study findings will be disseminated to study participants and through peer-reviewed publications and conference presentations, including user groups.Trial registration numberNCY02940873; Pre-results.


Diabetologia ◽  
2019 ◽  
Vol 62 (6) ◽  
pp. 1065-1073 ◽  
Author(s):  
Evita C. Wiegers ◽  
Hanne M. Rooijackers ◽  
Jack J.A. van Asten ◽  
Cees J. Tack ◽  
Arend Heerschap ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document